Investigation of the safety and efficacy of semaglutide s.c. in combination with NNC0480-0389 in participants with type 2 diabetes - a dose finding study(NN9389-4606)
Phase 2
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-jRCT2031210474
- Lead Sponsor
- Oyatani Akihito
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 495
Inclusion Criteria
Participants treated with diet and exercise as monotherapy or in combination with stable daily dose of any metformin formulations
Exclusion Criteria
Severe heart failure, History of chronic pancreatitis, other
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method